Bridgefront Capital, LLC

Position in JNJ — Johnson & Johnson

CIK 1725690 AUSTIN, TX

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,003,315

+$1,266,367 QoQ

Shares Held

7,888

+121.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.53%

of 13F equity value

Holder Rank

#2,350

of 4,676 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bridgefront Capital, LLC holds $6,932,010 across 7 Drug Manufacturers - General names. JNJ ranks #1 (28.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	7,888	$2,003,315
2	GILD	Gilead Sciences, Inc.	15,448	$1,951,700
3	PFE	Pfizer Inc	59,596	$1,435,071
4	LLY	ELI LILLY & Co	467	$560,133
5	NVS	Novartis AG	3,062	$479,876
6	GSK	GSK plc	6,458	$338,528
7	OGN	Organon & Co.	12,067	$163,387

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,003,315	7,888	+121.5%	Shares	Sole	2026-08-14
2025-12-31	$736,948	3,561	-42.9%	Shares	Sole	2026-02-13
2025-09-30	$1,156,649	6,238	+132.0%	Shares	Sole	2025-11-14
2024-12-31	$388,883	2,689	-37.6%	Shares	Sole	2025-02-14
2024-06-30	$629,364	4,306	+33.4%	Shares	Sole	2024-08-14
2024-03-31	$510,479	3,227	+127.6%	Shares	Sole	2024-05-15
2023-09-30	$220,853	1,418	-83.9%	Shares	Sole	2023-11-14
2023-03-31	$1,362,605	8,791	+206.3%	Shares	Sole	2023-05-15
2022-12-31	$506,985	2,870	+37.3%	Shares	Sole	2023-02-15
2022-09-30	$341,585	2,091	-47.1%	Shares	Sole	2022-11-29
2022-03-31	$700,058	3,950	-50.1%	Shares	Sole	2022-05-13
2021-03-31	$1,301,980	7,922	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.